STOCK TITAN
  1. Home
  2. VVUS

VVUS Stock Price, News & Analysis

VVUS NASDAQ

Company Description

VVUS (NASDAQ: VVUS) is a publicly traded pharmaceuticals: other company in the Health Technology sector.

VVUS stock has declined 86.2% over the past year.

This page provides a comprehensive overview of VVUS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-86.24%
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

VVUS (VVUS) stock. Over the past 12 months, the stock has lost 86.2%.

Latest News

View All
—

VIVUS Receives Court Approval of Joint Chapter 11 Plan of Reorganization

—

VIVUS Seeks Bankruptcy Court Approval of Second Amended Joint Chapter 11 Plan of Reorganization and Existing Stock Record Date

-15.79%

VIVUS Completes Solicitation for In-Court Reorganization Plan to Become a Wholly Owned Subsidiary of IEH Biopharma LLC

-0.89%

VIVUS Announces Updated Agreement with Icahn Enterprises Holdings L.P.

-6.78%

VIVUS Reports First Quarter 2020 Financial Results

earnings
-13.71%

VIVUS to Host First Quarter Business Update and Financial Results Conference Call on Wednesday, May 6, 2020

conferences earnings

VVUS has 7 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, conferences. View all VVUS news →

SEC Filings

View All

No SEC filings available for VVUS.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

VVUS Company Profile & Sector Positioning

VVUS (VVUS) operates in the Pharmaceuticals: Other industry within the broader Health Technology sector and is listed on the NASDAQ.